IGF Level in Breast Cancer Patients Treated With Metformin
Status:
Completed
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the impact of metformin as an adjuvant to
chemotherapy on IGF levels in both progressing and non progressing cases of metastatic breast
cancer in female patients.